Clinical Research Resources | Belmar Pharma Solutions

Plan ahead for shipping compounded medications around Labor Day. All Belmar Pharmacies are closed Monday, September 7th.

Refill Request

Search or filter clinical research to view results.

Chronic Pain and Inflammation

Largent-Milnes TM, Guo W, Wang HY, Burns LH, Vanderah TW. Oxycodone plus ultra-low-dose naltrexone attenuates neuropathic pain and associated mu-opioid receptor-Gs coupling. J Pain. 2008 Aug;9(8):700-13. doi: 10.1016/j.jpain.2008.03.005. Epub 2008 May 12. PMID: 18468954; PMCID: PMC5469510.

Chronic Pain and Inflammation

Crain SM, Shen KF. Antagonists of excitatory opioid receptor functions enhance morphine’s analgesic potency and attenuate opioid tolerance/dependence liability. Pain. 2000 Feb;84(2-3):121-31. doi: 10.1016/s0304-3959(99)00223-7. PMID: 10666516.

Chronic Pain and Inflammation

Cruciani RA, Lussier D, Miller-Saultz D, Arbuck DM. Ultra-low dose oral naltrexone decreases side effects and potentiates the effect of methadone. J Pain Symptom Manage. 2003 Jun;25(6):491-4. doi: 10.1016/s0885-3924(03)00139-8. PMID: 12782427.

Chronic Pain and Inflammation

Hay JL, La Vincente SF, Somogyi AA, Chapleo CB, White JM. Potentiation of buprenorphine antinociception with ultra-low dose naltrexone in healthy subjects. Eur J Pain. 2011 Mar;15(3):293-8. doi: 10.1016/j.ejpain.2010.07.009. Epub 2010 Aug 21. PMID: 20728384.

Chronic Pain and Inflammation

Webster LR, Butera PG, Moran LV, Wu N, Burns LH, Friedmann N. Oxytrex minimizes physical dependence while providing effective analgesia: a randomized controlled trial in low back pain. J Pain. 2006 Dec;7(12):937-46. doi: 10.1016/j.jpain.2006.05.005. PMID: 17157780.

Chronic Pain and Inflammation

Chindalore VL, Craven RA, Yu KP, Butera PG, Burns LH, Friedmann N. Adding ultralow-dose naltrexone to oxycodone enhances and prolongs analgesia: a randomized, controlled trial of Oxytrex. J Pain. 2005 Jun;6(6):392-9. doi: 10.1016/j.jpain.2005.01.356. PMID: 15943961.

Chronic Pain and Inflammation

Toljan K, Vrooman B. Low-Dose Naltrexone (LDN)-Review of Therapeutic Utilization. Med Sci (Basel). 2018 Sep 21;6(4):82. doi: 10.3390/medsci6040082. PMID: 30248938; PMCID: PMC6313374.

Pellet Therapy

Britto R, Araújo L, Barbosa I, Silva L.  Improvement of the lipid profile in post menopausal women who use estradiol and testosterone implants. Gynecological Endocrinology, 2012; 28(10):767-769.

Pellet Therapy

Kovac JR, Rajanahally S, Smith RP, Coward RM, Lamb DJ, Lipshultz LI. Patient satisfaction with testosterone replacement therapies: the reasons behind the choices.  J Sex Med, 2014; 11(2):553-62.

Call Center Image for Belmar Pharma Solutions Areas of Care

How can we help you?

Request a Refill

Become a Provider